HERMES Adult Respiratory Medicine flashcards
HERMES Adult Respiratory Medicine · Build recall with a focused review session.
34 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Asthma diagnostic criterion
- Variable expiratory airflow limitation with compatible symptoms, demonstrated by FEV1 improvement of more than 12% and more than 200 mL after inhaled salbutamol, or by peak flow variability over time.
- GOLD COPD spirometry threshold
- A post-bronchodilator FEV1 to FVC ratio below 0.70 confirms persistent airflow obstruction in a patient with symptoms and relevant exposure such as tobacco smoke or biomass fuel.
- Acute severe asthma magnesium dose
- Intravenous magnesium sulfate 2 g infused over 20 minutes is used for severe asthma not responding to inhaled bronchodilators and systemic corticosteroids in the first hour of treatment.
- NIV in COPD exacerbation
- Non-invasive ventilation reduces intubation and mortality in acute hypercapnic COPD exacerbation with pH 7.25 to 7.35 and PaCO2 above 45 mmHg, when no contraindication exists.
- Cystic fibrosis sweat chloride
- A sweat chloride concentration above 60 mmol/L confirms CFTR dysfunction when combined with compatible clinical features; values of 30 to 59 mmol/L are intermediate and require further testing.
- Usual interstitial pneumonia pattern
- High-resolution CT shows subpleural and basal-predominant reticulation, honeycombing, and traction bronchiectasis with minimal ground-glass change, supporting a diagnosis of idiopathic pulmonary fibrosis.
- Acute exacerbation of IPF
- New bilateral ground-glass opacities or consolidation on CT within one month of a respiratory decline, after excluding infection, heart failure, and pulmonary embolism; mortality exceeds 50 percent.
- Sarcoidosis radiographic staging
- Stage I is bilateral hilar lymphadenopathy, stage II adds parenchymal infiltrates, stage III is parenchymal infiltrates alone, and stage IV is pulmonary fibrosis with architectural distortion.
- Antifibrotic monitoring requirements
- Pirfenidone and nintedanib slow lung function decline in IPF but require baseline and periodic liver enzyme testing, plus attention to gastrointestinal side effects and photosensitivity.
- BAL lymphocytosis significance
- Bronchoalveolar lavage lymphocytosis above 25 to 30 percent suggests hypersensitivity pneumonitis or sarcoidosis, while eosinophils above 25 percent suggest eosinophilic pneumonia; results are supportive rather than diagnostic.
- Bronchiolitis management principles
- Infant bronchiolitis, usually caused by respiratory syncytial virus, is managed with supportive oxygen and feeding support; routine bronchodilators, corticosteroids, and antibiotics are not recommended.
- Croup corticosteroid treatment
- A single dose of oral dexamethasone 0.15 to 0.6 mg/kg treats croup; nebulised adrenaline is added for moderate to severe cases with stridor at rest.
- Primary ciliary dyskinesia features
- Neonatal respiratory distress, chronic wet cough, recurrent otitis media, and situs inversus in about half of patients, with low nasal nitric oxide and abnormal ciliary beat pattern.
- CF newborn screening pathway
- Elevated immunoreactive trypsinogen triggers CFTR mutation panel testing, followed by sweat chloride testing; sweat chloride above 60 mmol/L is diagnostic in an infant with compatible features.
- Pulmonary hypertension definition
- Mean pulmonary arterial pressure above 20 mmHg at rest defines pulmonary hypertension; precapillary disease also requires pulmonary vascular resistance of at least 3 Wood units and wedge pressure of 15 mmHg or less.
- PE haemodynamic risk stratification
- Haemodynamic instability defines high-risk pulmonary embolism requiring systemic thrombolysis or embolectomy; stable patients are stratified by sPESI, right ventricular function, and troponin.
- Chronic thromboembolic pulmonary hypertension
- Persistent perfusion defects on ventilation-perfusion scanning after at least three months of anticoagulation, with mean pulmonary arterial pressure above 20 mmHg; pulmonary endarterectomy is the preferred treatment.
- PAH vasoreactivity testing
- Acute vasoreactivity testing during right heart catheterisation identifies the roughly 10 percent of idiopathic PAH patients who may be treated with high-dose calcium channel blockers.
- ARDS Berlin definition
- Acute onset within one week, bilateral opacities not explained by effusion or collapse, and PaO2/FiO2 of 300 mmHg or less on PEEP of at least 5 cmH2O.
- Lung-protective ventilation targets
- Tidal volume of 6 mL/kg predicted body weight, plateau pressure of 30 cmH2O or less, and monitoring of driving pressure reduce mortality in acute respiratory distress syndrome.
- Rapid shallow breathing index
- Respiratory rate divided by tidal volume in litres; a value below 105 during a spontaneous breathing trial predicts successful extubation from mechanical ventilation.
- Predicted body weight formula
- For males, 50 plus 0.91 times height in centimetres minus 152.4; for females, 45.5 plus the same term. Used to set lung-protective tidal volumes.
- Prone positioning indication
- In moderate to severe ARDS with PaO2/FiO2 below 150 mmHg, prone positioning for at least 16 hours daily reduces mortality when applied early in the disease course.
- CURB-65 components
- Confusion, urea above 7 mmol/L, respiratory rate of 30 or more, low systolic or diastolic blood pressure, and age 65 or older; each scores one point for CAP severity.
- Latent tuberculosis regimens
- Options include four months of daily rifampicin, three months of weekly isoniazid plus rifapentine, or six to nine months of isoniazid; choice depends on interactions and liver risk.
- Pneumocystis prophylaxis threshold
- Co-trimoxazole prophylaxis is indicated when the CD4 count falls below 200 cells per microlitre; treatment doses are higher and adjunctive corticosteroids are added when PaO2 is below 70 mmHg.
- Complicated parapneumonic effusion
- Pleural fluid pH below 7.20, glucose below 2.2 mmol/L, or loculation indicates need for chest drainage; intrapleural fibrinolytics with DNase may be used for complex collections.
- OSA severity by AHI
- The apnoea-hypopnoea index grades obstructive sleep apnoea: mild is 5 to 15, moderate 15 to 30, and severe above 30 events per hour of sleep.
- CPAP adherence definition
- CPAP use of at least four hours per night on at least 70 percent of nights is the conventional threshold for adequate adherence and for expected cardiovascular benefit.
- Obesity hypoventilation syndrome
- Body mass index of 30 or more, daytime PaCO2 above 45 mmHg while awake, and sleep-disordered breathing without another cause of hypoventilation; treated with weight loss and nocturnal non-invasive ventilation.
- STOP-BANG screening score
- Snoring, tiredness, observed apnoea, pressure, body mass index, age, neck circumference, and gender; a score of 3 or more indicates high risk of obstructive sleep apnoea.
- NSCLC molecular testing panel
- Advanced non-squamous NSCLC requires testing for EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, and PD-L1; a driver mutation directs targeted therapy rather than chemotherapy.
- SCLC staging and treatment
- Small cell lung cancer is staged as limited or extensive; limited-stage disease is treated with concurrent chemoradiotherapy, and prophylactic cranial irradiation is considered in responders.
- Paraneoplastic hypercalcaemia in cancer
- Squamous cell lung carcinoma secretes PTH-related peptide causing hypercalcaemia; small cell carcinoma instead causes SIADH and ectopic ACTH, so the histology guides the expected syndrome.